CoChat

Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers

Open access
Lind, Johanna, Persson, Jonas, Ingvar, Martin, Larsson, Anne, Cruts, Marc, Van Broeckhoven, Christine, Adolfsson, Rolf, Bäckman, Lars, Nilsson, Lars-Göran, Petersson, Karl Magnus, Nyberg, Lars · 2006 · Brain
Cited by 148

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

The apolipoprotein E epsilon4 (APOE epsilon4) is the main known genetic risk factor for Alzheimer's disease. Genetic assessments in combination with other diagnostic tools, such as neuroimaging, have the potential to facilitate early diagnosis. In this large-scale functional MRI (fMRI) study, we have contrasted 30 APOE epsilon4 carriers (age range: 49-74 years; 19 females), of which 10 were homozygous for the epsilon4 allele, and 30 non-carriers with regard to brain activity during a semantic categorization task. Test groups were closely matched for sex, age and education. Critically, both groups were cognitively intact and thus symptom-free of Alzheimer's disease. APOE epsilon4 carriers showed reduced task-related responses in the left inferior parietal cortex, and bilaterally in the anterior cingulate region. A dose-related response was observed in the parietal area such that diminution was most pronounced in homozygous compared with heterozygous carriers. In addition, contrasts of processing novel versus familiar items revealed an abnormal response in the right hippocampus in the APOE epsilon4 group, mainly expressed as diminished sensitivity to the relative novelty of stimuli. Collectively, these findings indicate that genetic risk translates into reduced functional brain activity, in regions pertinent to Alzheimer's disease, well before alterations can be detected at the behavioural level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awl054

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Birn RM, Cox RW, Bandettini PA. Detection versus estimation in event-related fMRI: choosing the optimal stimulus timing. Neuroimage2002; 15: 252–64. · DOI · Paper page
  2. Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology1999; 52: 1861–70. · DOI · Paper page
  3. Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol2003; 60: 949–56. · DOI · Paper page
  4. Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry2002; 10: 44–51. · DOI
  5. Cedazo-Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med2001; 5: 254–66. · DOI · Paper page
  6. Chan AS, Butters N, Salmon DP, McGuire KA. Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. Psychol Aging1993; 8: 411–9. · doi:10.1037/0882-7974.8.3.411
  7. Chan AS, Butters N, Salmon DP. The deterioration of semantic networks in patients with Alzheimer's disease: a cross-sectional study. Neuropsychologia1997; 35: 241–8. · DOI
  8. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology2001; 57: 2223–8. · DOI · Paper page
  9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science1993; 261: 921–3. · DOI · Paper page
  10. Demb JB, Desmond JE, Wagner AD, Vaidya CJ, Glover GH, Gabrieli JD. Semantic encoding and retrieval in the left inferior prefrontal cortex: a functional MRI study of task difficulty and process specificity. J Neurosci1995; 15: 5870–8. · DOI · Paper page
  11. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology2002; 59: 746–8. · DOI · Paper page
  12. Dolan RJ, Fletcher PC. Dissociating prefrontal and hippocampal function in episodic memory encoding. Nature1997; 388: 582–5. · DOI · Paper page
  13. Duzel E, Habib R, Rotte M, Guderian S, Tulving E, Heinze HJ. Human hippocampal and parahippocampal activity during visual associative recognition memory for spatial and nonspatial stimulus configurations. J Neurosci2003; 23: 9439–44. · DOI · Paper page
  14. Elgh E, Larsson A, Eriksson S, Nyberg L. Altered prefrontal brain activity in persons at risk for Alzheimer's disease: an fMRI study. Int Psychogeriatr2003; 15: 121–33. · DOI
  15. Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM. 3D statistical neuroanatomical models from 305 MRI volumes. In: Proceedings of the IEEE-Nuclear Science Symposium and Medical Imaging Conference, San Francisco (CA); 1993. pp. 1813–7. · DOI · Paper page
  16. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–98. · DOI · Paper page
  17. Frackowiak RS, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain1981; 104: 753–78. · DOI · Paper page
  18. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging1999; 15: 365–75. · DOI · Paper page
  19. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology2000; 54: S10–5.
  20. Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, et al. Analysis of fMRI time-series revisited. Neuroimage1995; 2: 45–53. · DOI · Paper page
  21. Grady CL, Haxby JV, Horwitz B, Gillette J, Salerno JA, Gonzalez-Aviles A, et al. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging1993; 14: 35–44. · DOI
  22. Grossman M, Robinson K, Bernhardt N, Koenig P. A rule-based categorization deficit in Alzheimer's disease? Brain Cogn2001; 45: 265–76. · doi:10.1006/brcg.2000.1245
  23. Grossman M, Smith EE, Koenig P, Glosser G, DeVita C, Moore P, et al. The neural basis for categorization in semantic memory. Neuroimage2002; 17: 1549–61. · DOI
  24. Grossman M, Koenig P, Glosser G, DeVita C, Moore P, Rhee J, et al. Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. Brain2003; 126: 292–311. · DOI · Paper page
  25. Grundman M, Corey-Bloom J, Thal LJ. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. J Neural Transm Suppl1998; 53: 255–75. · DOI
  26. Grunwald T, Lehnertz K, Heinze HJ, Helmstaedter C, Elger CE. Verbal novelty detection within the human hippocampus proper. Proc Natl Acad Sci USA1998; 95: 3193–7. · DOI · Paper page
  27. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull2003; 65: 259–70. · DOI · Paper page
  28. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology1998; 50: 1585–93. · DOI · Paper page
  29. Kato T, Knopman D, Liu H. Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology2001; 57: 812–6. · DOI · Paper page
  30. Kiehl KA, Liddle PF, Smith AM, Mendrek A, Forster BB, Hare RD. Neural pathways involved in the processing of concrete and abstract words. Hum Brain Mapp1999; 7: 225–33. · DOI · Paper page
  31. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience1995; 67: 65–72. · DOI · Paper page
  32. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology2000; 54: S4–9.
  33. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia1994; 5: 36–41. · DOI · Paper page
  34. Nilsson L, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. The Betula Prospective Cohort Study: memory, health, and aging. Aging Neuropsychol Cogn1997; 4: 1–32. · DOI · Paper page
  35. Nilsson L, Adolfsson R, Backman L, de Frias C, Molander B, Nyberg L. Betula: a prospective cohort study on memory, health and aging. Aging Neuropsychol Cogn2004; 11: 134–48. · DOI · Paper page
  36. Price JL, Morris JC. Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer's disease. Ann Neurol1999; 45: 358–68. · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
  37. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA2005; 102: 8299–302. · DOI · Paper page
  38. Sano M. Current concepts in the prevention of Alzheimer's disease. CNS Spectr2003; 8: 846–53. · DOI
  39. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet1993; 342: 710–1. · DOI · Paper page
  40. Saykin AJ, Johnson SC, Flashman LA, McAllister TW, Sparling M, Darcey TM, et al. Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study. Brain1999; 122: 1963–71. · DOI · Paper page
  41. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA2002; 99: 4703–7. · DOI · Paper page
  42. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology1999; 53: 1391–6. · DOI · Paper page
  43. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology2002; 58: 1197–202. · DOI · Paper page
  44. Soininen H, Partanen K, Pitkanen A, Hallikainen M, Hanninen T, Helisalmi S, et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology1995; 45: 391–2. · DOI · Paper page
  45. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA1993; 90: 1977–81. · DOI · Paper page
  46. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett1997; 236: 21–4. · DOI
  47. Tulving E, Markowitsch HJ, Kapur S, Habib R, Houle S. Novelty encoding networks in the human brain: positron emission tomography data. Neuroreport1994; 5: 2525–8. · DOI · Paper page
  48. Wagner AD, Desmond JE, Glover GH, Gabrieli JD. Prefrontal cortex and recognition memory. Functional-MRI evidence for context-dependent retrieval processes. Brain1998; 121: 1985–2002. · DOI · Paper page
  49. Wagner AD, Koutstaal W, Maril A, Schacter DL, Buckner RL. Task-specific repetition priming in left inferior prefrontal cortex. Cereb Cortex2000; 10: 1176–84. · DOI · Paper page
  50. Weiss AP, Zalesak M, DeWitt I, Goff D, Kunkel L, Heckers S. Impaired hippocampal function during the detection of novel words in schizophrenia. Biol Psychiatry2004; 55: 668–75. · DOI
  51. Wenham PR, Newton CR, Price WH. Analysis of apolipoprotein E genotypes by the amplification refractory mutation system. Clin Chem1991; 37: 241–4. · DOI · Paper page

Cited by

See all 148

Metadata

Authors
Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Bäckman, L., Nilsson, L.-G., Petersson, K. M., & Nyberg, L.
Venue
Brain
Published
2006-03-14
Volume
129
Issue
5
Pages
1240-1248
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2114300989
Cited by
148
References
13
FWCI
9.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.